Explore the Federal Circuit's exclusive authority over pharmaceutical patent cases, covering key precedents like Mylan, Hatch-Waxman disputes, and the impact on generic drug timelines.
Mar, 25 2025
Sep, 11 2025
May, 5 2026
Jul, 9 2026
Aug, 13 2026